Galanin Type 1 Receptor Knockout Mice Show Altered Responses to High-fat Diet and Glucose Challenge

Overview

Journal Physiol Behav

Specialties Physiology
Psychiatry
Psychology
Social Sciences

Date 2007 Jan 16

PMID 17223141

Citations 17

Authors

E P Zorrilla

M Brennan

V Sabino

X Lu

T Bartfai

Affiliations

Soon will be listed here.

Abstract

Galanin, a brain and pancreatic peptide with three receptor subtypes (GALR1, GALR2, and GALR3), is hypothesized to participate in energy homeostasis and glucoregulation. Hypothalamic galanin expression is induced by dietary fat, and intra-hypothalamic galanin administration has orexigenic/anabolic properties. Systemic galanin infusion alters glucoregulation in non-human species, partly through direct actions on pancreatic islets. However, the physiologic significance of endogenous galanin-GALR signaling is unclear. The present studies tested the hypotheses that GALR1 deficiency alters food intake and feed efficiency following switches to high-fat diet and that GALR1 deficiency alters whole-body glucose homeostasis. Adult, male GALR1 knockout (-/-), heterozygote (+/-), and C57BL/6J control (+/+) mice were studied. GALR1 deficiency impaired adaptation to a 3-day high-fat diet challenge, leading to increased food intake, feed efficiency and weight gain. However, during the following 2 weeks, GALR1 knockout mice decreased intake, consuming less daily energy than while maintained on low-fat diet and also than heterozygote littermates. Chow-maintained GALR1 knockout mice showed relative hyperglycemia in fed and d-glucose (i.p. 1.5 g/kg)-challenged states. GALR1 knockout mice showed normal food intake, feed efficiency and weight accrual on low-fat diets, normal fasted glucose levels, and normal glucose sensitivity to porcine insulin (i.p. 1 IU/kg) in vivo. The results support the hypotheses that galanin-GALR1 systems help adapt food intake and metabolism to changes in dietary fat and modulate glucose disposition in mice.

Citing Articles

Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis.

Canova N, Sipkova J, Arora M, Pavlikova Z, Kucera T, Seda O Front Pharmacol. 2025; 16:1476994.

PMID: 39968178 PMC: 11832397. DOI: 10.3389/fphar.2025.1476994.

Neurotransmitters regulate β cells insulin secretion: A neglected factor.

Kong C, Cheng J, Wang W World J Clin Cases. 2023; 11(28):6670-6679.

PMID: 37901031 PMC: 10600852. DOI: 10.12998/wjcc.v11.i28.6670.

Intranasal Delivery of a Methyllanthionine-Stabilized Galanin Receptor-2-Selective Agonist Reduces Acute Food Intake.

Kuipers A, Balasko M, Petervari E, Koller A, Brunner S, Moll G Neurotherapeutics. 2021; 18(4):2737-2752.

PMID: 34859381 PMC: 8804135. DOI: 10.1007/s13311-021-01155-x.

Functions of galanin, spexin and kisspeptin in metabolism, mood and behaviour.

Mills E, Izzi-Engbeaya C, Abbara A, Comninos A, Dhillo W Nat Rev Endocrinol. 2020; 17(2):97-113.

PMID: 33273729 DOI: 10.1038/s41574-020-00438-1.

The Lateral Hypothalamus: An Uncharted Territory for Processing Peripheral Neurogenic Inflammation.

Fakhoury M, Salman I, Najjar W, Merhej G, Lawand N Front Neurosci. 2020; 14:101.

PMID: 32116534 PMC: 7029733. DOI: 10.3389/fnins.2020.00101.

References

Nagase H, Bray G, York D . Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue. Brain Res. 1996; 709(1):44-50. DOI: 10.1016/0006-8993(95)01292-3. View

Ryan M, Gundlach A . Localization of preprogalanin messenger RNA in rat brain: identification of transcripts in a subpopulation of cerebellar Purkinje cells. Neuroscience. 1996; 70(3):709-28. DOI: 10.1016/s0306-4522(96)83009-0. View

Hakansson M, Brown H, Ghilardi N, Skoda R, Meister B . Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci. 1998; 18(1):559-72. PMC: 6793379. View

Wang J, Leibowitz K . Central insulin inhibits hypothalamic galanin and neuropeptide Y gene expression and peptide release in intact rats. Brain Res. 1998; 777(1-2):231-6. DOI: 10.1016/s0006-8993(97)00963-3. View

Smith K, Walker M, Artymyshyn R, Bard J, Borowsky B, Tamm J . Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. J Biol Chem. 1998; 273(36):23321-6. DOI: 10.1074/jbc.273.36.23321. View

Kolakowski Jr L, ONeill G, Howard A, Broussard S, Sullivan K, Feighner S . Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J Neurochem. 1998; 71(6):2239-51. DOI: 10.1046/j.1471-4159.1998.71062239.x. View

Leibowitz S . Differential functions of hypothalamic galanin cell grows in the regulation of eating and body weight. Ann N Y Acad Sci. 1999; 863:206-20. DOI: 10.1111/j.1749-6632.1998.tb10696.x. View

Lu X, Mazarati A, Sanna P, Shinmei S, Bartfai T . Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity. Neuropeptides. 2005; 39(3):147-52. DOI: 10.1016/j.npep.2004.12.011. View

Leibowitz S . Regulation and effects of hypothalamic galanin: relation to dietary fat, alcohol ingestion, circulating lipids and energy homeostasis. Neuropeptides. 2005; 39(3):327-32. DOI: 10.1016/j.npep.2004.12.022. View

10.

Yun R, Dourmashkin J, Hill J, Gayles E, Fried S, Leibowitz S . PVN galanin increases fat storage and promotes obesity by causing muscle to utilize carbohydrate more than fat. Peptides. 2005; 26(11):2265-73. DOI: 10.1016/j.peptides.2005.04.005. View

11.

Dourmashkin J, Chang G, Gayles E, Hill J, Fried S, Julien C . Different forms of obesity as a function of diet composition. Int J Obes (Lond). 2005; 29(11):1368-78. DOI: 10.1038/sj.ijo.0803017. View

12.

Crawley J . The role of galanin in feeding behavior. Neuropeptides. 2000; 33(5):369-75. DOI: 10.1054/npep.1999.0049. View

13.

Branchek T, Smith K, Gerald C, Walker M . Galanin receptor subtypes. Trends Pharmacol Sci. 2000; 21(3):109-17. DOI: 10.1016/s0165-6147(00)01446-2. View

14.

Gundlach A, Burazin T, Larm J . Distribution, regulation and role of hypothalamic galanin systems: renewed interest in a pleiotropic peptide family. Clin Exp Pharmacol Physiol. 2001; 28(1-2):100-5. DOI: 10.1046/j.1440-1681.2001.03411.x. View

15.

Cheung C, Hohmann J, Clifton D, Steiner R . Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus. Neuroscience. 2001; 103(2):423-32. DOI: 10.1016/s0306-4522(01)00012-4. View

16.

Perez S, Wynick D, Steiner R, Mufson E . Distribution of galaninergic immunoreactivity in the brain of the mouse. J Comp Neurol. 2001; 434(2):158-85. DOI: 10.1002/cne.1171. View

17.

Swanson C, Blackburn T, Zhang X, Zheng K, Xu Z, Hokfelt T . Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci U S A. 2005; 102(48):17489-94. PMC: 1283534. DOI: 10.1073/pnas.0508970102. View

18.

Barr A, Kinney J, Hill M, Lu X, Biros S, Rebek Jr J . A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neurosci Lett. 2006; 405(1-2):111-5. DOI: 10.1016/j.neulet.2006.06.033. View

19.

Kyrkouli S, Strubbe J, Scheurink A . Galanin in the PVN increases nutrient intake and changes peripheral hormone levels in the rat. Physiol Behav. 2006; 89(1):103-9. DOI: 10.1016/j.physbeh.2006.05.009. View

20.

Odorizzi M, Fernette B, Angel E, Burlet C, Tankosic P, Burlet A . Galanin receptor antagonists decrease fat preference in Brattleboro rat. Neuropharmacology. 2001; 42(1):134-41. DOI: 10.1016/s0028-3908(01)00115-0. View